Furthermore, patients with T2DM are found to have lower circulating irisin levels (Liu et al., 2013; Yan et al., 2014), possibly due to the increased demand for sustaining glucose homeostasis and ameliorating insulin resistance in these individuals (Aladag, Mogulkoc & Baltaci, 2023). This evidence concerns the gene FNDC5 and type 2 diabetes mellitus.